Browse All

Current Filters

CLEAR FILTER x

TITLE

Metabolomics Approach to the Characterization of Novel Biomarkers in Multiple Sclerosis

Cortical Microglial Activation on [F-18]PBR06-PET Predicts Progression Independent of Relapse Activity (PIRA) in Multiple Sclerosis: A 4.5-year Longitudinal Study

Epigenetic Age is Minimally Correlated with Leukocyte Telomere Length in Pediatric Onset Multiple Sclerosis

Author:Yang, Jennifer   Race, Jonathan   Sumowski, Paige   Jacques, Kayla   Fardad, Soha   Fair, Ashley   Schuette, Allison   Lin, Jue   Yilmaz, Defne   Aaen, Gregory   Abrams, Aaron   Benson, Leslie   Casper, Charlie   Chitnis, Tanuja   Gorman, Mark   Lotze, Timothy   Krupp, Lauren   Mar, Soe   N,   

Session Name:P6: Multiple Sclerosis: Biomarkers and Immunology 2  

Topic:Multiple Sclerosis  

Program Number:P6.005  

Author Institution:UC San Diego, San Diego, CA  University of Utah , Salt Lake City, UT  University of California San Diego, San Diego, CA  Boston University, South Boston, MA  UC San Francisco, San Francisco, CA  UC Berkeley, Berkeley, CA  Loma Linda University School of Medicine, Loma Linda, CA  Cleveland Clinic Foundation, Cleveland, OH  Children's Hospital Boston, Boston, MA  Brigham and Women'S Hospital, Boston, MA  Texas Children's Hospital, Houston, TX  NYU Langone Medical Center, New York, NY  Washington University School of Medicine, Saint Louis, MO  UAB Dept of Pediatrics, Div Pediatric Neurology, Birmingham, AL  Cleveland Clinic, Chagrin Falls, OH  Imaging and Neurosciences Center, Salt Lake City, UT  University of Colorado/ Children's Hospital of Colorado, AURORA, CO  Mayo Clinic, Rochester, MN  Children's Hospital of Philadelphia, Philadelphia, PA  University of Alabama Birmingham, Birmingham, AL  University of California, Berkeley, Berkeley, CA  USCF MS Center, San Francisco, CA  UCSD, SAN DIEGO, CA  

Risk of Progression Independent of Relapse Activity and Disability Accumulation in a Real-world Cohort of Multiple Sclerosis Patients Initiated on High-efficacy Versus Low-efficacy Disease Modifying Therapy